Combination of Fractional CO2 Laser and Imiquimod in Pigmented Basal Cell Carcinoma: Preliminary Clinical Observations
Keywords:
Pigmented Basal Cell Carcinoma, Fractional CO2 Laser, Imiquimod, Combination Therapy, Preliminary Clinical OutcomesReferences
Peris K, Fargnoli MC, Kaufmann R, et al. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023. Eur J Cancer. 2023 Oct;192:113254. DOI: 10.1016/j.ejca.2023.113254
Omland SH, Wenande EC, Svane IM, Tam J, Olesen UH, Hædersdal M. Laser immunotherapy: A potential treatment modality for keratinocyte carcinoma. Vol. 13, Cancers. 2021; 13(21):5405. DOI: 10.3390/cancers13215405
Apalla Z, Lallas A, Tzellos T, et al. Applicability of dermoscopy for evaluation of patients’ response to nonablative therapies for the treatment of superficial basal cell carcinoma. Br J Dermatol. 2014 Apr;170(4):809–15. DOI: 10.1111/bjd.12749
Alma A, Pongetti L, Clementi A, et al. Combined Carbon Dioxide Laser with Photodynamic Therapy for Nodular Basal Cell Carcinoma Monitored by Reflectance Confocal Microscopy. Medicina (Lithuania). 2024 Jan 1;60(1). DOI: 10.3390/medicina60010030
Navarrete-Dechent C, Cordova M, Aleissa S, et al. Reflectance confocal microscopy confirms residual basal cell carcinoma on clinically negative biopsy sites before Mohs micrographic surgery: A prospective study. J Am Acad Dermatol. 2019 Aug;81(2):417–26. DOI: 10.1016/j.jaad.2019.02.049
Published
Issue
Section
License
Copyright (c) 2025 Luca Ambrosio, Giovanni Di Lella, Caterina Longo, Giovanni Pellacani, Iris Zalaudek, Claudio Conforti

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

